Diversion of prescribed opioids by people living with chronic pain: Results from an Australian community sample

Drug and Alcohol Review

Volumn 33, Issue 1, 2014, Pages 27-32

  Belcher, Jessica ^a   Nielsen, Suzanne ^b   Campbell, Gabrielle ^a   Bruno, Raimondo ^c   Hoban, Bianca ^a   Larance, Briony ^a   Lintzeris, Nicholas ^b,d   Degenhardt, Louisa ^a,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d The Langton Centre   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chronic pain; Diversion; Non adherence; Pharmaceutical opioids

Indexed keywords

NARCOTIC ANALGESIC AGENT;

AUSTRALIA; CHRONIC PAIN; ECONOMICS; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PRESCRIPTION; PRESCRIPTION DRUG DIVERSION; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; AUSTRALIA; CHRONIC PAIN; DATA COLLECTION; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUG DIVERSION;

EID: 84891928257     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12084     Document Type: Article

References (27)

1. Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011;195:280-284.
2. Roxburgh A, Burns L, Drummer OH, Pilgrim J, Farrell M, Degenhardt L. Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug Alcohol Rev 2013;32:269-275.
3. Leong M, Murnion B, Haber P. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009;39:676-681.
4. Cicero TJ, Inciardi JA, Surratt H. Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend 2007;91:115-120.
5. Kuehn BM. Methadone overdose deaths rise with increased prescribing for pain. JAMA 2012;308:749-750.
6. Kissin I. Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res 2013;6:513-529.
7. World Health Organization. Essential Medicines Library. Geneva: World Health Organization, http:/mednet3.who.int/EMLib/.
8. Ward L, Patel NM, Hanlon A, Eldakar-Hein S, Sherlinski K, Ward SH. Prescription medication borrowing among adult patients at an urban medical center. J Urban Health 2011;88:997-1014.
9. Goldsworthy RC, Schwartz NC, Mayhorn CB. Beyond abuse and exposure: framing the impact of prescription-medication sharing. Am J Public Health 2008;98:1115-1121.
10. Ellis J, Mullan J. Prescription medication borrowing and sharing: risk factors and management. Aust Fam Physician 2009;38:816-819.
11. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008;11(2 Suppl.):S63-88.
12. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med 2007;8:171-183.
13. Nielsen S, Bruno R, Degenhardt L, etal. The source of pharmaceuticals for problematic users of prescription opioids and benzodiazepines. Med J Aust in press.
14. Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MW. The 'black box' of prescription drug diversion. J Addict Dis 2009;28:332-347.
15. Medew J. Seniors selling off their drugs. The Sydney Morning Herald, 2012. Available at: http://www.smh.com.au/national/seniors-selling-off-their-drugs-20121117-29jb1.html (accessed October 21, 2013).
16. Walter S. Officers see more sick and elderly selling prescription drugs. The New York Times, 2010. Available at: http://www.nytimes.com/2010/09/19/us/19bcdealers.html?_r=0 (accessed October 21, 2013).
17. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med 2009;10:537-548.
18. Therapeutic Goods Administration. Standard for the Uniform Scheduling of Medicines and Poisons. Canberra: Australian Government Department of Health and Ageing, 2013. Available at: http://www.tga.gov.au/industry/scheduling-poisons-standard.htm/ (accessed 05/09/2013).
19. Mattick RP, Larance B, Bruno R, Black E, Lintzeris N, Degenhardt L, Nielsen S, Murnion B, Cohen M, Ali R, Dunlop A, Holland R. Minimising the unintended consequences of opioid treatment: development of a drug behaviour scale for use in Australia. Paper presented at College on Problems of Drug Dependence 74th Annual Meeting, Palm Springs, CA, 2012.
20. Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician 2012;15:ES191-203.
21. Arria AM, Garnier-Dykstra LM, Caldeira KM, Vincent KB, O'Grady KE. Prescription analgesic use among young adults: adherence to physician instructions and diversion. Pain Med 2011;12:898-903.
22. Fischer B, Bibby M, Bouchard M. The global diversion of pharmaceutical drugs: Non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 2010;105:2062-2070.
23. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998;51:253-263.
24. Chan D. So why ask me? Are self-report data really that bad? In: Lance CE, Vandenberg RJ, eds. Statistical and methodological myths and urban legends: doctrine, verity and fable in the organizational and social sciences. New York: Taylor & Francis, 2009:309-336.
25. AlMakadma YS, Simpson K. Opioid therapy in non-cancer chronic pain patients: trends and efficacy in different types of pain, patients age and gender. Saudi J Anaesth 2013;7:291-295.
26. Blyth FM, March LM, Brnabic AJM, Jorm LR, Williamson M, Cousins MJ. Chronic pain in Australia: a prevalence study. Pain 2001;89:127-134.
27. Stafford J, Burns L. Australia drug trends 2011: findings from the Illicit Drug Reporting System (IDRS) (Australian Drug Trends Series No. 73). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2012.